Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis

Osteoporosis International

Volumn 9, Issue 1, 1999, Pages 75-81

  Reginster, J Y ^a   Kuntz, D ^b   Verdickt, W ^c   Wouters, M ^d   Guillevin, L ^e   Menkes C J ^f   Nielsen, K ^g  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HÔPITAL LARIBOISIÈRE   (France)

^c AZ St Jozef ^*  (Belgium)

^d Ctr de Medicine Specialisée   (Belgium)

^e AVICENNE HOSPITAL   (France)

^f Groupe Hospitalier Cochin ^*  (France)

^g LEO PHARMA A S   (Denmark)

Author keywords

Alfacalcidol; Glucocorticosteroid; Human; Osteoporosis; Vitamin D

Indexed keywords

ALFACALCIDOL; CORTICOSTEROID; ONC ALPHA; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEMATOLOGY; HUMAN; LONG TERM CARE; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; CALCIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDNISOLONE; PROSPECTIVE STUDIES;

EID: 0033050332     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050118     Document Type: Article

References (29)

1. Michel BA, Bloch DA, Fries JF. Predictors of fracture in early rheumatoid arthritis. Rheumatology 1991;18:804-8.
2. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993;306:558.
3. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1993;309:265-8.
4. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving glucocorticosteroid therapy. Arch Intern Med 1990;150:2545-8.
5. Reifenstein EC. Control of corticoid-induced protein depletion and osteoporosis by anabolic steroid therapy. Metabolism 1958; 7: 78-9.
6. Schaat O, Bohr R. Alfacalcidol in prednisolone treatment: a controlled study of the effect on bone mineral density in lumbar spine, femoral neck and shaft. Calcif Tissue Int 1986;39:(Suppl): A58.
7. 3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double-blind controlled study. Clin Endocrinol 1983; 19: 265-73.
8. Schimner BP, Parker KL. Adrenocorticotropic hormone: In: Hardman JG, Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996:1466.
9. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
10. Geusens P, Dequeker J, Nijs J, Verstraeten A, Bramm E. Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D and prednisolone. Calcif Tissue Int 1991;48:127-37.
11. 3 on bone strength and composition in growing rats with and without corticosteroid treatment. Calcif Tissue Int 1994; 55:443-50.
12. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman JPrevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-52.
13. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
14. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 1993;3:322-9.
15. Jee WSS, Park HZ, Roberts WE, Kenner GH. Corticosteroid and bone. Am J of Anat 1970;129:477-81.
16. Duncan H. Osteoporosis in rheumatoid arthritis and corticosteroid induced osteoporosis. Orthop Clin North Am 1972;3:571-83.
17. Reid DM, Kennedy NSJ, Smith MA, et al. Total body calcium in rheumatoid arthritis: effects of disease and corticosteroid treatment. BMJ 1982;285:330-2.
18. Reid DM, Nicoll JJ, Brown N, et al. Bone mass in corticosteroid-treated patients with rheumatoid arthritis, asthma and polymyalgia rheumatica. Scottish Med J 1985;30:54-5.
19. Hajiroussou VJ, Webley M. Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. An Rheum Dis 1984;43:24-7.
20. Harris ED, Emkey RD, Nichols JE, Newberg A. Low dose prednisolone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983;10:713-21.
21. Lund B, Storm TL, Lund B, et al. Bone mineral loss, bone histomorphometry and vitamin metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment. Clin Rheumatol 1985;4:143-9.
22. Chavassieux P, Pastoureau P, Chapuy MC, Delmas PD, Meunier PJ. Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporos Int 1993;3:97-102.
23. Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss: a longitudinal study using computed tomography. Eur J Clin Pharmacol 1983;25:615-20.
24. Hodsman AB, Toogood JH, Jennings B, et al. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab 1991;72:530-40.
25. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss.J Bone Miner Res 1992;7:1063-9.
26. Hall GM, Daniels M, Doyle DV, Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994;37:1499-505.
27. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996;156:1173-7.
28. Healey JH, Paget SA, Williams-Russo P, Szatrowski TP, Schneider R, Spiera H, et al. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int 1996,58:73-80.
29. Greenwald M, Brandli D, Spector S, Silverman S, Golde G. Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride. Osteoporos Int 1992;2:303-4.